Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | 147,094 | reported | 08 Apr 2024 | tx 10+325,744 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 01 Feb 2024 | PURCHASE | CNS Pharmaceuticals, Inc. | 33,333 | 0.30 USD | |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 33,333 | — | deriv |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 33,333 | — | deriv |
| 21 Sept 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 68,961 | — | deriv |
| 08 Mar 2022 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 3,750 | 0.27 USD | |
| 15 Jul 2021 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 32,000 | — | deriv |
| 12 Jun 2020 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 46,559 | — | deriv |